Diabetes, Vol 44, Issue 10 1209-1212, Copyright © 1995 by American Diabetes Association
Treatment with insulin-like growth factor I alters capillary permeability in skin and retina
MA Hussain, K Studer, EP Messmer and ER Froesch
Division of Endocrinology and Metabolism, University Hospital of Zurich, Switzerland.
Treatment with insulin-like growth factor I (IGF-I) is accompanied by mild
generalized and reversible edema. These changes may be due to increased
capillary permeability. Therefore, we studied the effects of subcutaneous
IGF-I treatment in healthy subjects on capillary permeability of the skin
and the retina. Eight healthy subjects were treated with saline or
recombinant human IGF-I (rhIGF-I) (10 micrograms.kg-1.h-1 s.c.) in a
randomized crossover fashion. Transcapillary diffusion of sodium
fluorescein (NaF) was quantitated by video densitometry in the skin in all
subjects on the 4th treatment day. In seven subjects, plasma penetration of
NaF at the blood-retinal barrier was investigated using vitreous
fluorometry (VF) on days 3 and 5. Fluorescent light intensities of the skin
and plasma penetration determined by VF were significantly higher during
the IGF-I treatment as compared with those during the control situation. In
conclusion, IGF-I treatment at the above dose is accompanied by increased
transcapillary diffusion of NaF in skin and in retinal vessels.